FDA device listing
Fluorescein Conjugated Antiserum to Human Fibrinogen
FDA device listing 1835932359 · KENT LABORATORIES, INC.
Key facts
| Proprietary names | Fluorescein Conjugated Antiserum to Human Fibrinogen |
|---|---|
| Owner/operator | KENT LABORATORIES, INC. |
| Owner/operator number | 3019906 |
| Product codes | DAX |
| Device names | DAX - Fibrinogen And Split Products, Fitc, Antigen, Antiserum, Control |
| Device class | Class II |
| Classification regulations (21 CFR) | 864.7340 |
| Review panels | Hematology |
| Registered establishments | KENT LABORATORIES, INC. |
| Establishment registrations | 3019906 |
| FEI numbers | 3019906 |
| Establishment operations | Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None listed Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database